TrilynX: A phase 3 trial of xevinapant and concurrent chemoradiation for locally advanced head and neck cancer.

Jean Bourhis,Barbara Burtness,Lisa Licitra,Christopher M. Nutting,Jonathan D. Schoenfeld,Rafik Ait Sarkouh,Florilene Bouisset,Heidi Nauwelaerts,Yulia Urfer,Claudio Zanna,Ezra E.W. Cohen

TrilynX: A phase 3 trial of xevinapant and concurrent chemoradiation for locally advanced head and neck cancer.

2021

Jean Bourhis
Barbara Burtness
Lisa Licitra
Christopher M. Nutting
Jonathan D. Schoenfeld
Rafik Ait Sarkouh
Florilene Bouisset
Heidi Nauwelaerts
Yulia Urfer
Claudio Zanna
Ezra E.W. Cohen

TPS6091Background: Concurrent chemoradiotherapy (CRT) is the standard of care for previously untreated patients with locoregionally advanced squamous cell carcinomas of the head and neck (LA-SCCHN)...

Keywords:

Head and neck cancer
Radiology
locally advanced
Medicine
standard of care
concurrent chemoradiotherapy
concurrent chemoradiation
head and neck

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations